SARS-CoV-2 antibody prevalence, titres and neutralising activity in an antenatal cohort, United Kingdom, 14 April to 15 June 2020

SARS-CoV-2 IgG screening of 1,000 antenatal serum samples in the Oxford area, United Kingdom, between 14 April and 15 June 2020, yielded a 5.3% seroprevalence, mirroring contemporaneous regional data. Among the 53 positive samples, 39 showed in vitro neutralisation activity, correlating with IgG tit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Euro Surveill
Autors principals: Lumley, Sheila F, Eyre, David W, McNaughton, Anna L, Howarth, Alison, Hoosdally, Sarah, Hatch, Stephanie B, Kavanagh, James, Chau, Kevin K, Downs, Louise O, Cox, Stuart, Dunn, Laura, Justice, Anita, Wareing, Susan, Dingle, Kate, Rudkin, Justine, Auckland, Kathryn, Fyfe, Alexander, Bolton, Jai, Paton, Robert, Mentzer, Alexander J, Jeffery, Katie, Andersson, Monique I, James, Tim, Peto, Tim E A, Marsden, Brian D, Screaton, Gavin, Cornall, Richard J, Klenerman, Paul, Ebner, Daniel, Stuart, David I, Crook, Derrick W, Stoesser, Nicole, Kennedy, Stephen H, Thompson, Craig, Gupta, Sunetra, Matthews, Philippa C
Format: Artigo
Idioma:Inglês
Publicat: European Centre for Disease Prevention and Control (ECDC) 2020
Matèries:
Rapid Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651878/
https://ncbi.nlm.nih.gov/pubmed/33094717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars